Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Drug company (FDA labeler)

Vitruvias Therapeutics, Inc.

NDC labeler code: 69680

What is a labeler?

The company whose name is on the package and in the FDA’s National Drug Code (NDC) Directory. It may make the medicine itself or sell medicine made by another company. The first part of every NDC code identifies the labeler.

Official FDA data only

Products, approvals and recalls come from the FDA (NDC Directory, Drugs@FDA, enforcement reports). Recalls are linked to this company by the NDC labeler code on the recalled product.

Questions about your medicine: ask your doctor or pharmacist. In an emergency, call 911.

At a glance

14Products (NDC)

Prescription medicines

FDA applications for these products

  • ANDA: Abbreviated New Drug Application: how a generic version is approved.
ApprovedApplicationMedicineSponsor
August 6, 2025ANDA219156 Icosapent ethyl
ICOSAPENT ETHYL
Xiamen LP Pharm Co
July 15, 2025ANDA216901 Memantine and donepezil
MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE
Xiamen LP Pharm Co
November 5, 2024ANDA215638 Topiramate
TOPIRAMATE
Xiamen LP Pharm Co
October 11, 2022ANDA213985 Memantine hydrochloride
MEMANTINE HYDROCHLORIDE
H2-Pharma
June 11, 2021ANDA212797 Pramipexole dihydrochloride
PRAMIPEXOLE DIHYDROCHLORIDE
Xiamen LP Pharm Co

The sponsor is the company that holds the FDA application; it can differ from the labeler.

Recall timeline

2021

  1. March 15, 2021 · Class II · Terminated · D-0595-2021 · Cyanocobalamin

    CGMP Deviations: Intermittent exposure to temperature excursion during storage.

    CYANOCOBAL Injection 1000MCG/ML 25X1ML; NDC/UPC 69680-112-25; RX; MULTI DOSE VIAL

What do the recall classes mean?

Class I: The most serious type: there is a reasonable chance that using the product will cause serious health problems or death.
Class II: Using the product may cause temporary or medically reversible health problems, or the chance of serious problems is remote.
Class III: Using the product is not likely to cause health problems (for example a labeling or packaging issue).

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  3. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026

FDA Enforcement Report search → · Report an error →